SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia

Published:2018-11-15 Issue:4 Volume:184 Page:605-615
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Brander Danielle M.¹²^ORCID,Friedman Daphne R.¹²³^ORCID,Volkheimer Alicia D.³,Christensen Dale J.¹,Rassenti Laura Z.⁴,Kipps Thomas J.⁴,Guadalupe Eross¹,Chen Youwei¹,Zhang Dadong¹²,Wang Xi¹²,Davis Carter¹,Owzar Kouros¹²,Weinberg J. Brice¹²³

Affiliation:

1. Duke University Medical Center Durham NC USA

2. Duke Cancer Institute Durham NC USA

3. Durham VA Medical Center Durham NC USA

4. University of California San Diego Moores Cancer Center San Diego CA USA

Funder

U.S. Department of Veterans Affairs

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15677

Reference38 articles.

1. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia;Adachi Y.;Journal of Biological Chemistry,1994

2. Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia

3. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia

4. Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

5. Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms’ tumor;Carlson S.G.;Journal of the American Society of Nephrology,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Sphingosine Kinase 2 Results in PARK2-Mediated Mitophagy and Induces Apoptosis in Multiple Myeloma;Current Oncology;2023-03-04

2. Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer’s disease;Bioscience Reports;2022-11

3. The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐ α Action in Breast Cancer;Advanced Science;2022-07-17

4. Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities;Cellular Signalling;2022-03

5. The protein level of the tumour-promoting factor SET is regulated by cell density;The Journal of Biochemistry;2022-01-25